Equities

Morphic Holding Inc

Morphic Holding Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)28.94
  • Today's Change0.80 / 2.84%
  • Shares traded321.79k
  • 1 Year change-45.33%
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • MORF:NMQ price rises above 50-day moving average to 28.96 at 10:30 BST
  • MORF:NMQ price rises above 50-day moving average to 28.92 at 10:30 BST
  • MORF:NMQ price moved over +4.80% to 29.35
  • MORF:NMQ price rises above 50-day moving average to 29.35 at 10:30 BST
  • MORF:NMQ price falls below 15-day moving average to 27.86 at 10:35 BST
  • MORF:NMQ price rises above 15-day moving average to 29.35 at 10:30 BST

Key statistics

On Tuesday, Morphic Holding Inc (MORF:NMQ) closed at 28.94, 50.49% above the 52 week low of 19.23 set on Jun 13, 2022.
52-week range
Today
19.23Jun 13 202268.75Nov 05 2021
Markit short selling activity
Low
Med
High
Open28.59
High29.63
Low28.22
Bid20.00
Offer45.60
Previous close28.14
Average volume383.67k
Shares outstanding38.48m
Free float30.23m
P/E (TTM)--
Market cap971.16m USD
EPS (TTM)-1.43
USD
Data delayed at least 15 minutes, as of Oct 04 2022 21:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.